Francesco Cottone

Via Del Liceo 1
Perugia, 06123, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Toward Field Deployment: Tackling the Energy Challenge in Environmental Sensors.

Toward Field Deployment: Tackling the Energy Challenge in Environmental Sensors.

Journal: Sensors (Basel, Switzerland)

Published: July 31, 2025

Patient-reported outcomes in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia receiving standard chemotherapy plus quizartinib or placebo (QuANTUM-First): a global, randomised, placebo-controlled, phase 3 trial.

Patient-reported outcomes in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia receiving standard chemotherapy plus quizartinib or placebo (QuANTUM-First): a global, randomised, placebo-controlled, phase 3 trial.

Journal: The Lancet. Haematology

Published: July 22, 2025

Ultrasound-assisted synthesis of strontium-bismuth titanate and its application in environmental remediation.

Ultrasound-assisted synthesis of strontium-bismuth titanate and its application in environmental remediation.

Journal: Ultrasonics sonochemistry

Published: February 20, 2025

Tunable Hypersonic Resonators via Electron-Irradiation-Induced Giant Modulation of Microparticle Elasticity.

Tunable Hypersonic Resonators via Electron-Irradiation-Induced Giant Modulation of Microparticle Elasticity.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: October 31, 2024

Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBC.

Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBC.

Journal: The oncologist

Published: September 16, 2024

Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort.

Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 12, 2024

Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial.

Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial.

Journal: The Lancet. Oncology

Published: December 12, 2023

Real-Time AI-Assisted Push-Broom Hyperspectral System for Precision Agriculture.

Real-Time AI-Assisted Push-Broom Hyperspectral System for Precision Agriculture.

Journal: Sensors (Basel, Switzerland)

Published: November 30, 2023

3D-Printed Piezoelectret Based on Foamed Polylactic Acid for Energy-Harvesting and Sensing Applications.

3D-Printed Piezoelectret Based on Foamed Polylactic Acid for Energy-Harvesting and Sensing Applications.

Journal: Nanomaterials (Basel, Switzerland)

Published: November 01, 2023

The Optimization of Pressure-Assisted Microsyringe (PAM) 3D Printing Parameters for the Development of Sustainable Starch-Based Patches.

The Optimization of Pressure-Assisted Microsyringe (PAM) 3D Printing Parameters for the Development of Sustainable Starch-Based Patches.

Journal: Polymers

Published: August 27, 2023

Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia.

Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia.

Journal: Cancer

Published: May 12, 2023

The estimand framework had implications in time to patient-reported outcomes deterioration analyses in cancer clinical trials.

The estimand framework had implications in time to patient-reported outcomes deterioration analyses in cancer clinical trials.

Journal: Journal of clinical epidemiology

Published: March 02, 2023

Showing 1-12 of 76

Last Updated: 09/26/2026